Research, innovation, science and commitment

Research Figures

Data from the Scientific Report 2022

  • 489 Projects
  • 355 Clinical Trials
  • 802 Publications
  • 6332 Total Impact Factor

News

An innovative genetic analysis by Sant Joan de Déu and CNAG successfully diagnoses 23 children with neuromuscular diseases

The research, published in the scientific journal European Journal of Human Genetics, has been enabled by SolveRD, a project funded by the European Commission, in which Hospital Sant Joan de Déu and the Centro Nacional de Análisis Genómico (CNAG) participate

Gate2Brain Receives EMA Orphan Drug Designation for Its Groundbreaking Pediatric Cancer Treatment

Gate2Brain, has reached a major milestone in the fight against pediatric brain tumors by obtaining Orphan Drug Designation (ODD) from the European Medicines Agency (EMA) for its innovative product, G2B-002.

Interviews

César Galo Garcia Fontecha

Head of the Orthopaedic Surgery and Traumatology Group

“Learning about what others are doing allows us to improve and develop new ideas in order to advance in the world of research.”

Read more More Interviews

Agenda

Research Seminar: new targets and therapeutic tools for Glioblastoma.

Dr. J. Plaza Hall. Hospital Sant Joan de Déu. Esplugues de Llobregat

Research Seminar: Computational modeling of serotonergic modulation in the prefrontal circuit for working memory in schizophrenia and Its Implications

Speaker: Dr. Albert Compte. Theoretical Neurobiology. Systems Neuroscience. IDIBAPS.

Dr. J. Plaza Hall (Hospital Sant Joan de Deu, Esplugues de Llobregat)